DXCM vs LNTH · P/E 63, rev $2.50B vs P/E 23, rev $765.5M
DexCom Inc (DXCM) versus Lantheus Holdings Inc (LNTH) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Lantheus Holdings Inc (LNTH) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported LNTH revenue for 2026-06-30 was $765.5M. Net income was $193.4M. LNTH currently screens at market cap $5.56B and trailing P/E 22.9.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. LNTH currently screens at market cap $5.56B and trailing P/E 22.9.
Not investment advice. Open the DXCM and LNTH stock pages for the full models.
Not investment advice.